| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 10 | -262K | 100% | $38.01 | -$9.94M |
| Net | -10 | -262K | -100% | -$9.94M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Marc Stapley | Chief Executive Officer, Director | $9.34M | -$2.23M | -19.3% | Sep 4, 2025 |
| Bonnie Anderson | Director | $5.58M | Jun 2, 2023 | ||
| Rebecca Chambers | Chief Financial Officer | $5.17M | -$613K | -10.6% | Nov 5, 2025 |
| Tina Susan Nova | President, CLIA U.S. | $4.78M | Mar 3, 2022 | ||
| Phillip G. Febbo | Chief Scientific & Med Officer | $3.33M | -$742K | -18.2% | Oct 6, 2025 |
| Annie McGuire | SVP, General Counsel | $3.32M | -$1.27M | -27.7% | Nov 5, 2025 |
| John Leite | Chief Commercial Officer-CLIA | $3.12M | -$640K | -17% | Oct 1, 2025 |
| Robert S. Epstein | Director | $2.19M | -$753K | -25.6% | Oct 1, 2025 |
| Giulia C. Kennedy | Chief Scientific & Med Officer | $1.75M | Dec 6, 2022 | ||
| Jonathan Wygant | VP, Chief Accounting Officer | $1.64M | -$707K | -30.1% | Nov 7, 2025 |
| Eliav Barr | Director | $1.58M | Jun 18, 2025 | ||
| Evan/ Fa Jones | Director | $1.41M | -$1.95M | -57.9% | Nov 5, 2025 |
| John L. Bishop | Director | $1.28M | Jul 17, 2023 | ||
| Muna Bhanji | Director | $1.21M | -$122K | -9.17% | Jun 18, 2025 |
| Jens Holstein | Director | $1.15M | Jun 18, 2025 | ||
| Thomas F. Miller | Director | $797K | Jun 18, 2025 | ||
| David Brent Shafer | Director | $797K | Jun 18, 2025 | ||
| Karin Eastham | Director | $542K | -$913K | -62.7% | Nov 5, 2025 |
| Jane Alley | VP, Corporate Controller | $345K | May 17, 2021 | ||
| Kevin K. Gordon | Director | $231K | Jun 8, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|